Videos

• Presentation at the XV^th World congress of the transplantation society.

Online Presentations

(May require login or free registration at the website)

• Medscape: Colon Cancer in Liver Transplant Recipients

• Medscape: Posttransplant Lymphoproliferative Disorders in Liver Transplantation A 20-Year Experience

Slide Presentations

• Liver transplantation in 4000 consecutive patients with 2-18 years follow-up, cause of death and indications for retransplantation.

• Use of intravenous mycophenolate mofetil and delayed introduction of low dose oral tacrolimus to preserve renal function in living donor liver transplantation.

• Relevance of ribavirin level in post liver transplant patients for recurrence of hepatitis C viral infection.

• Tacrolimus for primary liver transplantation: 12 - 15 years actual follow-up in 1000 consecutive patients with safety profile.

• Does Valganciclovir hydrochloride (Valcyte^™) provide effective prophylaxis against Cytomegalovirus (CMV) infection in liver transplant recipients?

• University of wisconsin (UW) versus histidine-tryptophan-ketoglutarate (HTK) for tissue preservation in live donor liver transplantation

Posters

• Correlation of hepatitis c viral (HCV) antibody titre with hepatitis c viral load, hepatic injury and response to anti-HCV treatment in post liver transplant (LTx) patients.

• Survival outcome after hepatic retransplantation for hepatitis c viral positive and negative recipients

• Safety and efficacy of pegylated interferon alfa-2b (Pegintron®) v/s pegylated interferon alfa-2a (Pegasys®) in post liver transplant (LTx) hepatits c virus (HCV) genotype 1a/1b patients

• University of wisconsin (UW) versus histidine - tryptophan - ketoglutarate (HTK) for tissue preservation in live donor liver transplantation

• Ribavirin levels in post liver transplant (LTx) patients treated for recurrent hepatitis c viral (HCV) infection